Renal cell carcinoma
Conditions
Interventions
Index test:Multimodal Fusion Model
Sponsors
The Third Medical Centre, Chinese PLA General Hospital, Beijing, China
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Cases were obtained from a participating center during the prespecified study period. 2. A final diagnosis of renal cell carcinoma was established through pathological reassessment. 3. At least one analyzable hematoxylin-and-eosin-stained whole-slide image from a renal needle-biopsy specimen was available. 4. A definitive reference classification as clear cell or non-clear cell renal cell carcinoma was available.
Exclusion criteria
Exclusion criteria: 1. No renal needle-biopsy specimen was available. 2. The biopsy specimen or whole-slide image was unsuitable for analysis because of insufficient tissue, severe artifacts, poor staining quality, or other technical limitations. 3. A definitive reference classification as clear cell or non-clear cell renal cell carcinoma could not be established through pathological reassessment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Area under the receiver operating characteristic curve (AUROC); | — |
Secondary
| Measure | Time frame |
|---|---|
| Sensitivity;Specificity;Accuracy;F1 score; | — |
Countries
China
Contacts
Public ContactGu Liangyou
The Third Medical Centre, Chinese PLA General Hospital, Beijing 100039, China
Outcome results
None listed